Acceptance, efficacy, and safety of COVID-19 vaccination in older patients with cancer

authors

• Couderc Anne-Laure
• Ninove Laetitia
• Nouguerède Emilie
• Rey Dominique
• Rebroin Marina
• Daumas Aurélie
• Tomasini Pascale
• Greillier Laurent
• Salas Sebastien
• Duffaud Florence
• Dahan Laetitia
• Duluc Muriel
• Garcia Marie-Eve
• Pluvy Johan
• Chaléat Solène
• Farnault Laure
• Venton Geoffroy
• Fourié Toscane
• Nurtop Elif
• de Lamballerie Xavier
• Villani Patrick
• Charrel Remi
• Correard Florian

keywords

• Immunotherapy
• Lenvatinib
• Pembrolizumab
• Second-line
• Thymic epithelial tumors
• Aged
• COVID-19
• Drug-related side effects and adverse reactions
• Geriatric assessment
• Medical oncology
• Vaccination

abstract

The COVID-19 vaccination campaign began in December 2020, in France, and primarily targeted the oldest people. Our study aimed to determine the level of acceptance of vaccination in a population of older patients with cancer.

more information